TCL Archive Supreme Court Decision Means FTC Scrutiny As Costly Oncology Drugs Go Off-Patent June 21, 2013
TCL Archive ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial. September 8, 2006
TCL Archive In Brief: Gregory Curt May Return As Director Of COP; Koop Locked In as Surgeon General Until Nov. January 20, 1989
